Knowing Now
Moves Us™
Transforming work-flow in healthcare
Products in development, patent pending. The FDA or other notified bodies have not reviewed the products shown on this page.
OUR PORTFOLIOs
Rapid and affordable detection, prevention, and treatment.
Products in development, patent pending. The FDA or other notified bodies have not reviewed the products shown on this page.
- Better Access
- Improved Workflow
- Low Cost
- Faster Clinical Decisions
OUR PARTNERS
Advanced testing capabilities
With multiple technologies for detection we have the right detection technology for each test and healthcare setting.
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions.
Sapphiros Laboratories is CLIA certified and operates on a national scale with comprehensive clinical and digital solutions to provide a seamless collection, testing and reporting solution.
Biocrucible is developing a novel proprietary molecular technology platform to enhance and accelerate the behaviour and kinetics of engineered biological systems.
GoToKnow™ is a direct to consumer sales channel that empowers you to take charge of your health through a portfolio of diagnostic tests, and your wellness through a suite of wellness-focused genomic tests.
ABOUT
Unlocking new frontiers in diagnostic and delivery innovation
Satio is at the forefront of self-diagnostics and at home drug and vaccine delivery. Blood is still the best diagnostic sample in history, but collection methods remain difficult, painful, and messy. Satio brings a Dried Blood Spot and Whole Blood collection to the consumer; simple, painless, and clean. With our patent-pending designs, patients now have access to simple, affordable options to draw blood, mix reagents and detect an array of pathogens all on a patch placed on your arm. In addition, Satio patch technology also allows for painless delivery of drugs and vaccines. These devices may eliminate the need for needles and administration by medical professionals. Moving forward, Satio continues to evolve to include a broader spectrum of advanced diagnostic and therapeutic capabilities. With the ability to provide patients the right detection and delivery technology on a global scale.
Products in development, patent pending. The FDA or other notified bodies have not reviewed the products shown on this page.